What Does Peritoneal Nodule Mean?

The peritoneum is a thin membrane. It lines the inside of the abdominal wall and wraps most of the organs inside. It is one continuous sheet with a large surface area. A small amount of fluid keeps it slippery so the bowel can slide.

A peritoneal nodule is a lump sitting on that lining. On a CT or MRI report you may also see "peritoneal deposits," "peritoneal implants," "peritoneal thickening," "omental caking," or "peritoneal carcinomatosis." Those terms describe the same process at different sizes.

Not every peritoneal nodule is cancer. Benign causes exist. They include scar tissue from past surgery, endometriosis, small spleen fragments, and infections such as tuberculosis. But in someone with a known cancer, or with unexplained belly fluid, the radiologist flags it because it can change the stage.

Tumors on the peritoneum usually arrive by spillage, not through the bloodstream. A cancer that reaches the outer surface of an organ sheds cells into the fluid. That fluid moves with breathing and gravity. The cells settle where the flow slows.

So deposits cluster in the same few places. The pouch behind the uterus or bladder. The right side under the diaphragm. And the omentum, the fatty apron hanging from the stomach. When the omentum thickens and mats with tumor, radiologists call it an omental cake.

Common primaries include ovarian, appendiceal, colorectal, gastric, and pancreatic cancers, and peritoneal mesothelioma.

Ascites means fluid in the belly. It often goes with peritoneal nodules. It causes swelling, feeling full early in a meal, weight gain, and sometimes breathlessness when it presses on the diaphragm. New ascites should lead to more imaging.

The fluid can be drained with a needle. This is called a paracentesis. It eases pressure and sends cells to the lab. Cytology on that fluid confirms cancer if malignant cells turn up. A negative result does not rule cancer out. Tumor cells are not always shed in numbers a lab can find. So the two answers are not equal. A positive result settles it. A negative one does not.

If ovarian cancer is suspected, CA-125 is the most recommended blood marker. Its limits are worth knowing. It is raised in most advanced epithelial ovarian cancers. But it is raised in only about 50 percent of early-stage cases. In a postmenopausal woman, a CA-125 above 35 U/mL means high risk of cancer. CA-125 also feeds into the Risk of Malignancy Index, along with ultrasound findings and menopausal status.

If the plan involves surgery, one score dominates: the Peritoneal Cancer Index, or PCI.

The surgeon divides the abdomen and pelvis into 13 regions. Nine are abdominopelvic regions, numbered 0 to 8. Four are small bowel regions, numbered 9 to 12. Each region gets a size score from 0 to 3:

• 0: no visible tumor.
• 1: deposits up to 0.5 cm.
• 2: deposits between 0.5 and 5 cm.
• 3: deposits over 5 cm, or confluent disease.

Adding the 13 regional scores gives a total PCI from 0 to 39. A higher PCI means a lower chance of removing everything and a worse outlook.

The thresholds for offering surgery differ by where the cancer started:

• Appendiceal tumors: PCI up to about 20 to 21.
• Colorectal: PCI up to about 15 to 20.
• Gastric: PCI up to about 10.

Ask what your PCI was, or is estimated to be. It is a far more informative number than "several nodules."

Some people are offered cytoreductive surgery, or CRS. It strips the affected peritoneum and removes organs that are involved. Heated chemotherapy is then washed through the abdomen. That step is called HIPEC. For colorectal primaries the usual drugs are mitomycin C or oxaliplatin. They are run at 40 to 43 degrees Celsius for 60 to 90 minutes. Cisplatin and paclitaxel are also used.

The outcome is graded by how complete the removal was:

• CC-0: no visible residual disease.
• CC-1: residual nodules 2.5 mm or smaller.
• CC-2: residual nodules between 2.5 mm and 2.5 cm.
• CC-3: residual nodules over 2.5 cm.

Only CC-0 and CC-1 count as optimal. Neither CC-2 nor CC-3 is linked to a meaningful survival gain from HIPEC. Across tumor types, how complete the removal was is the strongest predictor of outcome. Incomplete removal gives no survival gain over palliative care. It still carries the full surgical risk.

That is why a surgeon may open the abdomen and then stop. It is a considered decision, not a failure.

The risk side is substantial. Across reported series, major complications run 19 to 44 percent, and serious grade 3 or higher complications 9 to 40 percent. Deaths range from 0 to 2.3 percent. The rate is higher during a center's learning curve, and when several organs must be removed. Complications include fistulas, abscesses, a hole in the bowel, and kidney failure. Older age, frailty, poor nutrition, low albumin, and an ASA score of 3 or higher all raise the risk.

• How many nodules, how large, and in which regions?
• Is this a new finding, or was it present on my last scan?
• Do we have tissue or fluid confirming what it is?
• Was a cytology sent, and if it was negative, what does that change?
• Am I a candidate for cytoreductive surgery, and what is my estimated PCI?
• Which center in my region does this operation regularly, and how many a year?

• A hard, rigid, exquisitely tender abdomen. This can mean a perforation.
• Belly pain with vomiting and no gas or stool passing, which suggests obstruction.
• Breathlessness at rest, or you cannot lie flat.
• Fever of 100.4 F (38 C) or higher with abdominal pain, especially if you are on chemotherapy.
• Any drainage, or fever, after a recent abdominal procedure.

Call your team the same day for rapidly increasing abdominal swelling over days without those features.

What Does Ascites Mean on a Scan?, What Does Omental Caking Mean?, Ovarian Cancer, and What Metastatic Cancer Means.

• https://www.ncbi.nlm.nih.gov/books/NBK570563/
• https://www.ncbi.nlm.nih.gov/books/NBK567760/
• https://www.cancer.gov/types/ovarian/hp/ovarian-epithelial-treatment-pdq